Superinfection and the evolution of an initial asymptomatic stage
Chadi M Saad-Roy1, Bryan T Grenfell2,3,4, Simon A Levin2
1Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA.
Abstract:
Pathogens have evolved a variety of life-history strategies. An important strategy consists of successful transmission by an infected host before the appearance of symptoms, that is, while the host is still partially or fully asymptomatic. During this initial stage of infection, it is possible for another pathogen to superinfect an already infected host and replace the previously infecting pathogen. Here, we study the effect of superinfection during the first stage of an infection on the evolutionary dynamics of the degree to which the host is asymptomatic (host latency) in that same stage. We find that superinfection can lead to major differences in evolutionary behaviour. Most strikingly, the duration of immunity following infection can significantly influence pathogen evolutionary dynamics, whereas without superinfection the outcomes are independent of host immunity. For example, changes in host immunity can drive evolutionary transitions from a fully symptomatic to a fully asymptomatic first infection stage. Additionally, if superinfection relative to susceptible infection is strong enough, evolution can lead to a unique strategy of latency that corresponds to a local fitness minimum, and is therefore invasible by nearby mutants. Thus, this strategy is a branching point, and can lead to coexistence of pathogens with different latencies. Furthermore, in this new framework with superinfection, we also find that there can exist two interior singular strategies. Overall, new evolutionary outcomes can cascade from superinfection.
Insights
Superinfection, where a new pathogen invades an infected host, significantly alters pathogen evolution. This process impacts host immunity effects on pathogen latency and can lead to diverse evolutionary strategies and pathogen coexistence.
Area of Science:
- Evolutionary biology
- Pathogen dynamics
- Infectious disease ecology
Background:
- Pathogens evolve diverse life-history strategies, including transmission during asymptomatic (latent) infection stages.
- Superinfection, the invasion of an already infected host by a new pathogen, can occur during this early infection phase.
Purpose of the Study:
- To investigate the evolutionary impact of superinfection on host latency during the initial infection stage.
- To understand how superinfection influences pathogen evolutionary dynamics and strategies.
Main Methods:
- Mathematical modeling of pathogen evolution under superinfection pressure.
- Analysis of the role of host immunity duration and superinfection intensity.
Main Results:
- Superinfection introduces significant evolutionary differences, making pathogen dynamics dependent on host immunity duration, unlike scenarios without superinfection.
- Strong superinfection can drive evolution towards unique latency strategies at fitness minima, promoting pathogen coexistence with varying latencies.
- The presence of superinfection can lead to the emergence of two interior singular strategies.
Conclusions:
- Superinfection fundamentally alters pathogen evolutionary trajectories, influencing host latency and leading to novel evolutionary outcomes.
- Host immunity duration becomes a critical factor in pathogen evolution when superinfection is prevalent.
- Superinfection can create evolutionary branching points, fostering pathogen diversity and coexistence.
Related Concept Videos
Stages of Infection
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Urinary Tract Infection II: Pathophysiology
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Viral Recombination
Viral Mutations


